Iradimed Sinks 30% On Sharply Cut Guidance

Iradimed Corp IRMD shares are trading lower by $5.76 (33 percent) at $11.25 in Tuesday's session. The catalyst for the decline is sharply lower guidance announced after Monday's close.

Q3 EPS guidance was slashed from $0.91-$0.93 to $0.60-$0.63 and FY sales guidance from $9.90-$10 million to $7.50-$7.60 million.

After drifting lower in after-hours and pre-market trading, the issue opened sharply lower ($12.24 vs. Monday's close of $17.01) and could only manage a $0.30 bounce to $12.54. Instantly, panic-sellers flooded the issue, taking it all the way to $9.76 in just two minutes.

The current low coincides with its December 15, 2014 low of $9.79.

Since rebounding from that depressed level, the issue has consolidated at the $11.20 area over the past hour.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceTechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!